Guidance

AI Airlock Simulation Workshops

Key insights of simulation workshops from the AI Airlock testing programme. You should note that these documents are not formal guidance.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 16 October 2025
• Last updated: 9 June 2026
  Show all updates

  1. 9 June 2026

     This page has been updated to include three new simulation workshop reports from the second phase of reporting.

  2. 16 October 2025

     First published.

Documents

AI Airlock Post-Market Surveillance Simulation Report

PDF, 478 KB, 9 pages

AI Airlock Explainability Simulation Report

PDF, 682 KB, 10 pages

AI Airlock Hallucination Simulation Report

PDF, 451 KB, 9 pages

AI Airlock AI In-Vitro Diagnostics Simulation Report

PDF, 526 KB, 12 pages

AI Airlock Post Market Surveillance and PCCPs Simulation Report

PDF, 537 KB, 17 pages

AI Airlock Scope of Intended Purpose Simulation Report

PDF, 550 KB, 12 pages

Details

During the AI Airlock, the MHRA hosted Simulation workshops exploring key regulatory challenge areas.

Each session brought together a diverse group of representatives from across industry, clinical practice, regulation, academia and technology. Participants included experts from the MHRA, NICE, NHS and a range of partner organisations. Their insights and collaborative contributions were instrumental in shaping the discussions and recommendations outlined in these reports.